By Arun Ramesh, Lead Analyst, Beroe Inc.   Abstract 1 Serialization – Need of the HourLack of global co-operation on agreement with one common technology over the years has delayed […]

Hepalink USA, the wholly owned U.S. subsidiary of Shenzhen Hepalink Pharmaceutical, will acquire the biopharmaceutical contract development manufacturing organization Cytovance® Biologics for $205.68 million cash plus additional contingent payments, Cytovance […]